Insiders · CYCN

CYCN insider transactions

Cyclerion Therapeutics Inc. (CYCN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CYCN

• 257d
  SEC Form 4 filed by Chief Financial Officer Chicko Rhonda M.

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 394d
  Director Hecht Peter M was granted 181,818 shares, increasing direct ownership by 48% to 559,203 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 394d
  Director Higgins Michael J was granted 9,090 shares, increasing direct ownership by 42% to 30,740 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 516d
  Large owner Slate Path Capital Lp sold $555,108 worth of shares (357,880 units at $1.55) (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 626d
  SEC Form 4 filed by Officer Graul Regina Margaret

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 775d
  New insider Chicko Rhonda M. claimed ownership of 18 shares (SEC Form 3)

  3 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 820d
  Hecht Peter M was granted 15,000 shares, increasing direct ownership by 4% to 377,385 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 820d
  Graul Regina Margaret was granted 50,000 shares, increasing direct ownership by 99% to 100,303 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 866d
  New insider Katabi Dina claimed ownership of 20,000 shares (SEC Form 3)

  3 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 870d
  New insider Higgins Michael J claimed ownership of 21,650 shares (SEC Form 3)

  3 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 870d
  New insider Graul Regina Margaret claimed ownership of 50,303 shares (SEC Form 3) (Amendment)

  3/A - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 873d
  New insider Graul Regina Margaret claimed ownership of 50,000 shares (SEC Form 3)

  3 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 873d
  Mcguire Terrance was granted 5,000 shares, increasing direct ownership by 906% to 5,552 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 873d
  Hecht Peter M was granted 35,000 shares, increasing direct ownership by 11% to 362,385 units (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 873d
  Desouza Errol B was granted 50,000 shares (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 873d
  Hyman Steven was granted 20,000 shares (SEC Form 4)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 988d
  SEC Form 4: Mcguire Terrance sold $27 worth of shares (8 units at $3.40)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1069d
  SEC Form 4 filed by Hecht Peter M

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1368d
  SEC Form 4 filed by Hyman Steven (Amendment)

  4/A - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1369d
  SEC Form 4 filed by Hyman Steven

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1369d
  SEC Form 3: New insider Hyman Steven claimed no ownership of stock in the company

  3 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1409d
  SEC Form 4 filed by Mendelsohn Michael

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1409d
  SEC Form 4 filed by Mcguire Terrance

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1409d
  SEC Form 4 filed by Conrades George H

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1409d
  SEC Form 4 filed by Lovell Stephanie

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1409d
  SEC Form 4 filed by Fanucci Marsha

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1409d
  SEC Form 4 filed by Isacson Ole

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1409d
  SEC Form 4 filed by Desouza Errol B

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1553d
  SEC Form 4 filed by Busch Andreas

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1553d
  SEC Form 4 filed by Gjino Anjeza

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1553d
  SEC Form 4 filed by Hecht Peter M

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1553d
  SEC Form 4 filed by Gault Cheryl

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1597d
  SEC Form 4 filed by Busch Andreas

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1597d
  SEC Form 4 filed by Gjino Anjeza

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1597d
  SEC Form 4 filed by Gault Cheryl

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1762d
  SEC Form 4 filed by Lovell Stephanie

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1762d
  SEC Form 4 filed by Fanucci Marsha

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1762d
  SEC Form 4 filed by Isacson Ole

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1762d
  SEC Form 4 filed by Churchwell Kevin

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1762d
  SEC Form 4 filed by Mendelsohn Michael

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1762d
  SEC Form 4 filed by CONRADES GEORGE H

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1762d
  SEC Form 4 filed by DESOUZA ERROL B

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1762d
  SEC Form 4 filed by MCGUIRE TERRANCE

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1783d
  SEC Form 4: MCGUIRE TERRANCE bought $299,997 worth of Common Stock (96,153 units at $3.12)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1783d
  SEC Form 4 filed by Cyclerion Therapeutics, Inc.

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1783d
  SEC Form 4: Slate Path Capital LP bought $2,999,999 worth of Common Stock (961,538 units at $3.12)

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1812d
  SEC Form 4: Hecht Peter M bought $733,860 worth of Common Stock (302,000 units at $2.43), increasing direct ownership by 33% to 1,224,528 units

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1815d
  SEC Form 4: Hecht Peter M bought $1,693,943 worth of Common Stock (698,001 units at $2.43), increasing direct ownership by 311% to 922,528 units

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1881d
  SEC Form 4: Anjeza Gjino sold $7,296 worth of Common Stock (1,824 units at $4.00), decreasing ownership by 5% to 31,599 units

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)
• 1881d
  SEC Form 4: I Christopher Wright sold $10,522 worth of Common Stock (2,637 units at $3.99), decreasing ownership by 6% to 42,728 units

  4 - Cyclerion Therapeutics, Inc. (0001755237) (Issuer)